Amar Mohee is a consultant urological surgeon. His NHS practice is at the Manchester University NHS Foundation Trust (MFT), working primarily at the Manchester Royal Infirmary.
Amar did his medical training at the University of Manchester, before moving across the Pennines to undertake research in urology at the University of Leeds. He was awarded a doctorate in medicine for his thesis titled ‘Infection in urological practice: bacteraemia and infective endocarditis.’ Following his research, he moved back to Manchester to complete his urological training. Before starting as a consultant surgeon at the Manchester Royal Infirmary, Amar moved to Paris for a fellowship in robotic surgery and uro-oncology at the prestigious Henri Mondor Hospital, APHP, France. He is currently the lead in urological cancer at the Manchester Royal Infirmary.
Amar practises all aspects of urology but has a sub-speciality interest in urological cancer (prostate, bladder, kidney and testis). He has presented extensively at national and international conferences. He is also well published on various aspects of urological practice including erectile dysfunction, premature ejaculation, urinary incontinence and urinary infections.
Amar speaks English and French fluently. Outside work, Amar enjoys spending time with his wife and two young children. Time permitting, Amar is a keen baker, with his son being his harshest critique.
Amar has introduced a number of new services at the Manchester University NHS Foundation Trust since he has been appointed as a consultant surgeon including:
Magnetic Resonance Fusion Local Anaesthetic Transperineal Prostate Biopsy (MR Fusion LATP). This is a novel technique to biopsy the prostate for patients suspected of having prostate cancer. This technique involves fusing images from the MR scan of the prostate with the ultrasound images used during prostate biopsies, to allow more accurate targeting of lesions in the prostate.
Robotic Surgery for managing cancer of the bladder. Amar uses the Intuitive Da Vinci robot to operate on the bladder and prostate to treat cancer. This minimally invasive technique allows for more delicate manoeuvres during surgery and quicker recovery post-surgery.